KOHJIN BIO CO LTD (177A.T)

JPY 1700.0

(-0.99%)

Operating Expenses Summary of KOHJIN BIO CO LTD

  • KOHJIN BIO CO LTD's latest annual operating expenses in 2023 was 1.28 Billion JPY , up 8.24% from previous year.
  • KOHJIN BIO CO LTD's latest quarterly operating expenses in 2023 FY was 1.28 Billion JPY , up 8.24% from previous quarter.
  • KOHJIN BIO CO LTD reported a annual operating expenses of 1.18 Billion JPY in annual operating expenses 2022, up 10.94% from previous year.
  • KOHJIN BIO CO LTD reported a annual operating expenses of 1.06 Billion JPY in annual operating expenses 2021, down 0.0% from previous year.
  • KOHJIN BIO CO LTD reported a quarterly operating expenses of 345.41 Million JPY for 2023 Q4, down 0.0% from previous quarter.
  • KOHJIN BIO CO LTD reported a quarterly operating expenses of 1.18 Billion JPY for 2022 FY, up 10.94% from previous quarter.

Annual Operating Expenses Chart of KOHJIN BIO CO LTD (2023 - 2021)

Historical Annual Operating Expenses of KOHJIN BIO CO LTD (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 1.28 Billion JPY 8.24%
2022 1.18 Billion JPY 10.94%
2021 1.06 Billion JPY 0.0%

Peer Operating Expenses Comparison of KOHJIN BIO CO LTD

Name Operating Expenses Operating Expenses Difference
PRISM BioLab Co.,LTD 576.81 Million JPY -122.684%
GNI Group Ltd. 9.32 Billion JPY 86.222%
Linical Co., Ltd. 2.7 Billion JPY 52.518%
Trans Genic Inc. 2.15 Billion JPY 40.529%
MEDINET Co., Ltd. 1.49 Billion JPY 13.861%
Soiken Holdings Inc. 3.07 Billion JPY 58.175%
Cytori Cell Research Institute, Inc. 1.85 Billion JPY 30.83%
AnGes, Inc. 8.9 Billion JPY 85.571%
OncoTherapy Science, Inc. 943.08 Million JPY -36.2%
Nxera Pharma Co., Ltd. 19.19 Billion JPY 93.307%
Immuno-Biological Laboratories Co., Ltd. 412.99 Million JPY -211.018%
NanoCarrier Co., Ltd. 975.37 Million JPY -31.691%
Carna Biosciences, Inc. 2.56 Billion JPY 49.973%
CanBas Co., Ltd. 278 Million JPY -362.041%
D. Western Therapeutics Institute, Inc. 1.14 Billion JPY -12.522%
RaQualia Pharma Inc. 1.81 Billion JPY 29.345%
Chiome Bioscience Inc. 1.6 Billion JPY 19.909%
Kidswell Bio Corporation 2.37 Billion JPY 45.896%
PeptiDream Inc. 9.68 Billion JPY 86.741%
Oncolys BioPharma Inc. 1.96 Billion JPY 34.485%
Ribomic Inc. 1.1 Billion JPY -16.169%
SanBio Company Limited 4.53 Billion JPY 71.701%
Healios K.K. 3.48 Billion JPY 63.164%
BrightPath Biotherapeutics Co., Ltd. 1.15 Billion JPY -11.235%
Kubota Pharmaceutical Holdings Co., Ltd. 1.33 Billion JPY 3.746%
Delta-Fly Pharma, Inc. 1.4 Billion JPY 8.478%
StemRIM 2.07 Billion JPY 38.128%
CellSource Co., Ltd. 1.96 Billion JPY 34.582%
FunPep Company Limited 313.82 Million JPY -309.301%
Kringle Pharma, Inc. 958.01 Million JPY -34.077%
Stella Pharma Corporation 963.98 Million JPY -33.246%
TMS Co., Ltd. 943.25 Million JPY -36.175%
Noile-Immune Biotech Inc. 1.08 Billion JPY -17.847%
Cuorips Inc. 598.11 Million JPY -114.752%
K Pharma,Inc. 543.94 Million JPY -136.142%
Takara Bio Inc. 23.9 Billion JPY 94.627%
ReproCELL Incorporated 1.51 Billion JPY 15.161%
PhoenixBio Co., Ltd. 1.18 Billion JPY -8.487%
StemCell Institute Inc. 1.16 Billion JPY -10.528%
Japan Tissue Engineering Co., Ltd. 1.52 Billion JPY 15.622%
CellSeed Inc. 804.93 Million JPY -59.576%